CatSci to participate at a panel discussion at PharmaTech Integrates 2024

CatSci Ltd, an award-winning innovation partner for medicines development, is excited to announce that we will be sponsoring and attending PharmaTech Integrates 2024. Our Director of New Modalities, Dr Nigel Richardson, will also be participating in a panel discussion entitled ‘The Oligos/Peptides Revolution for Patients, the NHS, and the UK Economy.’

Taking place on 19th September 2024, PharmaTech Integrates will be held in Glasgow, Scotland.

We are looking forward to discussing how CatSci can meet your dynamic project demands with tailored solutions in oligonucleotides CMC development.

Attending PharmaTech Integrates 2024 will be: 

• Dr Nigel Richardson, Director of New Modalities
• Dr Sam Whitmarsh, Director of Analytical Science and Digital Transformation
• Dr Joe Renny, Head of Corporate Development

Book a meeting with us to discover more about CatSci’s oligonucleotides capabilities:  

• Material Supply
• Process R&D
• Analytical Science
• CMC

To arrange a meeting at PharmaTech Integrates 2024, get in touch here.  

Find out more about our expert oligonucleotides services here.